Holocene Advisors
CRL icon

Holocene Advisors’s Charles River Laboratories CRL Stock Holding History

Holocene Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-26,144
Closed -$3.94M – 775
2025
Q1 		$3.94M Buy
+26,144
New +$4.38M 0.01% 427
2024
Q2 		– Sell
-32,078
Closed -$8.69M – 727
2024
Q1 		$8.69M Buy
+32,078
New +$7.66M 0.03% 303
2023
Q2 		– Sell
-1,830
Closed -$369K – 743
2023
Q1 		$369K Sell
1,830
-4,938
-73% -$1.12M ﹤0.01% 665
2022
Q4 		$1.47M Sell
6,768
-144,377
-96% -$31.5M 0.01% 494
2022
Q3 		$29.7M Buy
+151,145
New +$32.6M 0.19% 150

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Holocene Advisors's CRL Position: Q2 2025 in Review

Holocene Advisors sold out of Charles River Laboratories (CRL) in Q2 2025, closing a stake of 26,144 shares — an estimated $3.94M sold.

Holocene Advisors first reported a position in CRL in Q3 2022 and held it in 5 quarters. The position peaked at $29.7M in Q3 2022. 518 funds tracked by Wall St. Rank hold CRL as of Q2 2025.

  • Holocene Advisors reported no remaining Charles River Laboratories position as of Q2 2025 after selling out during the quarter.
  • Holocene Advisors sold 26,144 Charles River Laboratories shares in Q2 2025, an estimated $3.94M.
  • Holocene Advisors first reported a position in Charles River Laboratories in Q3 2022 and held it in 5 quarters.
  • Holocene Advisors's Charles River Laboratories position peaked at $29.7M in Q3 2022.
  • 518 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.

Based on Holocene Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.